Article Details

Amsterdam-based Leyden Labs raises €40M to develop intranasal products against coronaviruses

Retrieved on: 2021-03-29 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Amsterdam-based Leyden Labs raises €40M to develop intranasal products against coronaviruses. View article details on hiswai:

Excerpt

... in its Series A round of funding led by GV (formerly Google Ventures), with participation from F-Prime Capital, Casdin Capital, LLC and Brook Byers.

Article found on: siliconcanals.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo